
Sign up to save your podcasts
Or


Professor Tim Walsh is a professor of critical care and leads for the Edinburgh Critical Care Research Group. His main interests are pragmatic clinical trials, epidemiology, and quality improvement research. He currently leads three major research programmes in the areas of blood and blood product transfusion, recovery following critical illness, and sedation management in the ICU.
Professor Walsh has key strategic roles with the National Institute of Healthcare Research (Chair of UK Critical Care Specialty Group), Chief Scientists Office (Critical Care Specialty Group lead and member of the Research Strategy Oversight Group), and through national professional societies (Chairman, Scottish Critical Care Trials Group; Member of UK Intensive Care Society Research Committee). He is a strong believer in collaborative national and international research and the importance of research networks.
His vision is to lead a world-class multidisciplinary group undertaking bench to bedside research, always keeping patient-centred outcomes as the central focus of the group’s activities.
By ANZICSProfessor Tim Walsh is a professor of critical care and leads for the Edinburgh Critical Care Research Group. His main interests are pragmatic clinical trials, epidemiology, and quality improvement research. He currently leads three major research programmes in the areas of blood and blood product transfusion, recovery following critical illness, and sedation management in the ICU.
Professor Walsh has key strategic roles with the National Institute of Healthcare Research (Chair of UK Critical Care Specialty Group), Chief Scientists Office (Critical Care Specialty Group lead and member of the Research Strategy Oversight Group), and through national professional societies (Chairman, Scottish Critical Care Trials Group; Member of UK Intensive Care Society Research Committee). He is a strong believer in collaborative national and international research and the importance of research networks.
His vision is to lead a world-class multidisciplinary group undertaking bench to bedside research, always keeping patient-centred outcomes as the central focus of the group’s activities.